Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma: Targeting Early Intervention to Achieve Best Outcomes

Sunday, March 19

Join us to learn how neoadjuvant immunotherapy fits into the treatment plan for many patients with surgically resectable cutaneous squamous cell carcinoma. Discover why timing matters when giving your patients the best chance of a pathological complete response after resection.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

When: Sunday, March 19 | 6:45 p.m. Registration | 7 p.m. Program
Where: Gravier Ballrooms A-D | Marriott Warehouse Arts District Hotel
View more information and register.

Ai Cme2x